Opinion

Video

Tisotumab Vedotin for Patients With Cervical Cancer

Author(s):

Claire Friedman, MD,Emily Davan, RN

Comprehensive insights on the journey of a patient with cervical cancer and treatment options upon progression, with a focus on tisotumab vedotin.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Related Content
Gleevec and Mektovi was associated with benefits among patients with GIST: © stock.adobe.com.
August 20th 2025

New Treatment Combo Shows Benefit for Patients with GIST

Alex Biese
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
August 20th 2025

A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More

Alex Biese Brielle Benyon
Advocacy text.
August 20th 2025

When Cancer Advocacy Becomes a Lifeline

Morgan Newman
Kate Weissman, a gynecologic cancer survivor
August 20th 2025

Fertility Research ‘Long Overdue’ for Patients With Cervical Cancer

Alex Biese
Biomarker testing is vital for all patients with lung cancer: © stock.adobe.com.
August 20th 2025

Biomarker Testing Remains Crucial for Young Patients With Lung Cancer

Spencer Feldman
A phase 1 trial has initiated and is investigating treatment with ziftomenib plus Gleevec in advanced GIST: © stock.adobe.com.
August 20th 2025

First Patient Dosed in Trial of Ziftomenib for Advanced GIST

Spencer Feldman